SUPPORTIVE CARE IN CANCER, vol.20, no.2, pp.385-393, 2012 (SCI-Expanded)
The effectiveness of carboplatin and vincristine chemotherapy in the treatment of low-grade glioma (LGG) is well established. However, carboplatin hypersensitivity reactions (CHR) are a major problem leading to premature cessation of therapy. We aimed to investigate the clinical features and the management strategies in CHR, retrospectively.